Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Total	Series A Non Voting Convertible Preferred Stock	Series B Non Voting Convertible Preferred Stock	Preferred Stock Series A Non Voting Convertible Preferred Stock	Preferred Stock Series B Non Voting Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023					150,000
Beginning balance at Dec. 31, 2023					$ 84,555
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs (in shares)					122,000
Issuance of Series A/B non-voting convertible preferred stock in connection with private placement, net of financing costs					$ 168,850
Ending balance (in shares) at Mar. 31, 2024					272,000
Ending balance at Mar. 31, 2024					$ 253,405
Beginning balance, preferred stock (in shares) at Dec. 31, 2023				437,000
Beginning balance at Dec. 31, 2023	$ 184,016			$ 184,927		$ 10	$ 763,191	$ 302	$ (764,414)
Beginning balance, common stock (in shares) at Dec. 31, 2023						36,057,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)						572,000
Issuance of common stock in connection with exercise of stock options and employee stock purchase plan	4,390						4,390
Stock-based compensation expense	8,385						8,385
Foreign currency translation adjustment	16							16
Unrealized gain (loss) on marketable securities	(681)							(681)
Net loss	(43,857)	$ (12,642)	$ (4,810)						(43,857)
Ending balance, preferred stock (in shares) at Mar. 31, 2024				437,000
Ending balance at Mar. 31, 2024	152,269			$ 184,927		$ 10	775,966	(363)	(808,271)
Ending balance, common stock (in shares) at Mar. 31, 2024						36,629,000
Beginning balance, preferred stock (in shares) at Dec. 31, 2024		346,045	16,667	346,000	17,000
Beginning balance at Dec. 31, 2024	$ 517,804			$ 146,425	$ 9,395	$ 13	1,334,223	180	(972,432)
Beginning balance, common stock (in shares) at Dec. 31, 2024	60,257,023					60,257,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with exercise of stock options and employee stock purchase plan (in shares)						19,000
Issuance of common stock in connection with exercise of stock options and employee stock purchase plan	$ 335						335
Stock-based compensation expense	8,859						8,859
Cash settlement of stock option award	(117)						(117)
Foreign currency translation adjustment	14							14
Unrealized gain (loss) on marketable securities	488							488
Net loss	(44,773)	$ (8,288)	$ (399)						(44,773)
Ending balance, preferred stock (in shares) at Mar. 31, 2025		346,045	16,667	346,000	17,000
Ending balance at Mar. 31, 2025	$ 482,610			$ 146,425	$ 9,395	$ 13	$ 1,343,300	$ 682	$ (1,017,205)
Ending balance, common stock (in shares) at Mar. 31, 2025	60,275,561					60,276,000